BMBartosz Meglicki

Bartosz Meglicki

*This is an algorithmically generated author record based on publicly available information.

Bartosz Meglicki has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Agnieszka Misiarz

    National Centre for Nuclear Research , Andrzeja Sołtana 7 Otwock , Poland

    1 shared publication
  • Agnieszka Syntfeld-Każuch

    National Centre for Nuclear Research, 05-400 Otwock, Poland

    1 shared publication
  • Anna Wysocka-Rabin

    Particle Acceleration Physics and Technology Division, National Centre for Nuclear Research (NCNR) , Poland

    1 shared publication
  • Eugeniusz Pławski

    Nuclear Techniques & Equipment Department, National Centre for Nuclear Research (NCBJ), 7 Andrzeja Sołtana Str., 05-400 Otwock/Świerk, Poland, Tel.: +48 22 273 1412, Fax: +48 22 779 3481

    1 shared publication
  • Ewa Kulczycka

    Nuclear Techniques & Equipment Department, National Centre for Nuclear Research (NCBJ), 7 Andrzeja Sołtana Str., 05-400 Otwock/Świerk, Poland, Tel.: +48 22 273 1412, Fax: +48 22 779 3481

    1 shared publication
  • Kaja Swat

    Nuclear Techniques & Equipment Department, National Centre for Nuclear Research (NCBJ), 7 Andrzeja Sołtana Str., 05-400 Otwock/Świerk, Poland, Tel.: +48 22 273 1412, Fax: +48 22 779 3481

    1 shared publication

Latest Publications

  • Open Access

    The IOERT IntraLine accelerator – the development, current state, and future plans

    by Przemysław Adrich, Radosław Hanke, Ewa Kulczycka, Konrad Kosiński, Bartosz Meglicki, Agnieszka Misiarz, Eugeniusz Pławski, Marcin Staszczak, Kaja Swat, Agnieszka Syntfeld-Każuch, et al.

    Intraoperative electron radiation therapy (IOERT) is a cancer treatment method that combines oncologic surgery with electron beam radiotherapy. This method can reduce the duration of entire tumor treatment and increase its effectiveness. Moreover, shortening the treatment time significantly reduces the cost and accessibility of the therapy. As a result of interdisciplinary research, an innovative accelerator for IOERT, the IntraLine, was developed. In the course of this work, four patent applications were filed. Today, the work is half way through. In the near future, the device will be optimized. New mechanical design solutions will be developed. Mechanical optimization will significantly reduce the weight of the device. Accelerators control system, which today is in the demo phase, will also be significantly upgraded. This paper describes the stages of the IntraLine accelerator development, its current state and plans for the future R&D work, within the scope of our new Intra-Dose project.